Drugs News and Research

RSS

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

A gene that is overexpressed in some aggressive cancers also appears to be key to the excessive cell proliferation that thickens the walls of pulmonary arteries and ultimately causes the right ventricle of the heart to fail, scientists report.

16 Dec 2021

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

An international team have mapped how the HTLV-1 virus causes a rare leukemia in some people, providing clues on how to stop it happening.

16 Dec 2021

Scientists find better treatment options for patients with advanced colorectal cancer

City of Hope, a world-renowned cancer research and treatment organization, today announced study results of a Phase 2 clinical trial showing monotherapy with sotorasib resulted in anti-tumor activity and a favorable benefit-risk profile among heavily pretreated patients with advanced colorectal cancer. The research was published today in Lancet Oncology.

16 Dec 2021

New combined therapy shows promising results in treating triple negative breast cancer

A drug used to treat cardiac failure has shown promising results in treating triple negative breast cancer, according to Houston Methodist researchers who released results this week on a new combined therapy with the potential to improve outcomes for these hard-to-treat breast cancer patients.

15 Dec 2021

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

15 Dec 2021

Survey shows significant decrease in percentage of adolescents reporting substance use in 2021

The percentage of adolescents reporting substance use decreased significantly in 2021, according to the latest results from the Monitoring the Future survey of substance use behaviors and related attitudes among eighth, 10th, and 12th graders in the United States.

15 Dec 2021

Largest declines in adolescent use of illicit drugs reported in 2021

Declines in adolescent use of illicit drugs reported in 2021 were the largest and most sweeping ever recorded in the past 46 years, according to the Monitoring the Future study.

15 Dec 2021

Researchers spot signs of 'pre-resistance' in bacteria for the first time

Scientists have spotted signs of 'pre-resistance' in bacteria for the first time – signs that particular bacteria are likely to become resistant to antibiotics in the future – in a new study led by UCL and Great Ormond Street Hospital researchers.

15 Dec 2021

Australian scientists discover an enzyme that is key to why exercise improves metabolic health

Monash University, Australia scientists have discovered an enzyme that is key to why exercise improves our health.

15 Dec 2021

Treatment with whole plant medicinal cannabis reduces epileptic seizure frequency in children

Epileptic seizure frequency fell by an average of 86% among 10 children treated with whole plant medicinal cannabis, reveals a case series, published in the open access journal BMJ Paediatrics Open.

15 Dec 2021

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

High pressure (hyperbaric) oxygen resolves severe breathing difficulties in COVID-19 patients much more quickly than standard therapy, taking an average of 3 rather than 9 days, reveal the results of a small comparative clinical trial published online in Emergency Medicine Journal.

15 Dec 2021

Structure of human receptor and Omicron variant

Researchers studied the complex structure of the receptor-binding domain of the omicron variant with the human host receptor angiotensin-converting enzyme 2.

15 Dec 2021

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Depixus®, a biotechnology company, today announces it has raised EUR 30.6 million in an oversubscribed Series A financing.

From Depixus® 15 Dec 2021

Frequent cognitive impairments after 4-month follow-up in ICU COVID-19 patients

Results from a recent observational study published in the Journal Of The Neurological Sciences found that after a 4-month follow-up, ICU patients with severe COVID-19 illness were more likely to have mild cognitive impairment with features related to a diffuse encephalopathy than patients with mild infection who do not need a ventilator. Additionally, ICU patients experienced more significant impairment in executive function. All neurological deficits involve the peripheral nervous system.

14 Dec 2021

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

A team of US-based scientists has recently explored various risk factors associated with the poor prognosis of coronavirus disease 2019 (COVID-19). They have identified thrombosis-related risk factors as a major predictor of in-hospital COVID-19 related mortality. The study is currently available on the medRxiv* preprint server while awaiting peer review.

14 Dec 2021

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

An international research team co-led by scientists at Roswell Park Comprehensive Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has identified an important accelerator of treatment-resistant prostate cancer.

14 Dec 2021

Survey finds increase in American adults skipping medical care due to cost

Nearly one-third (30%) of Americans skipped needed medical care in the past three months due to cost, the highest reported number since the COVID-19 pandemic began and a threefold increase from March to October, according to the latest survey from the nonprofit, nonpartisan organization West Health and Gallup, the global analytics and advice firm.

14 Dec 2021

Driving up immunity at tumor site may help enhance immunotherapy treatments

Driving up the immune response at the site of a cancer tumor with nanotechnology may help enhance immunotherapy treatments in advanced stages of the disease, new research in mice suggests.

14 Dec 2021

Study reveals molecular players involved in the onset of leukemia

A new study led by João T. Barata from Instituto de Medicina Molecular João Lobo Antunes (iMM, Portugal), and J. Andrés Yunes from Centro Infantil Boldrini (Brazil), published now in the scientific journal Nature Communications, shows that changes in a protein called IL-7R are sufficient to initiate a type of leukemia.

14 Dec 2021

Salk study could help find better treatment options for colorectal cancer patients

Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues.

14 Dec 2021

Drugs News and Research

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

Researchers map how the HTLV-1 virus causes a rare leukemia in some people

Scientists find better treatment options for patients with advanced colorectal cancer

New combined therapy shows promising results in treating triple negative breast cancer

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Survey shows significant decrease in percentage of adolescents reporting substance use in 2021

Largest declines in adolescent use of illicit drugs reported in 2021

Researchers spot signs of 'pre-resistance' in bacteria for the first time

Australian scientists discover an enzyme that is key to why exercise improves metabolic health

Treatment with whole plant medicinal cannabis reduces epileptic seizure frequency in children

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

Structure of human receptor and Omicron variant

Depixus Raises EUR 30.6M (USD 35.4M) in Series A Financing

Frequent cognitive impairments after 4-month follow-up in ICU COVID-19 patients

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

Study provides new insights into molecular drivers of treatment resistance in prostate cancer

Survey finds increase in American adults skipping medical care due to cost

Driving up immunity at tumor site may help enhance immunotherapy treatments

Study reveals molecular players involved in the onset of leukemia

Salk study could help find better treatment options for colorectal cancer patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News